Citigroup Issues Pessimistic Forecast for agilon health (NYSE:AGL) Stock Price

agilon health (NYSE:AGL) had its price objective dropped by analysts at Citigroup from $2.50 to $1.75 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage presently has a “sell” rating on the stock. Citigroup’s price objective would indicate a potential downside of 5.41% from the stock’s previous close.

A number of other research firms also recently weighed in on AGL. JMP Securities downgraded agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday. Deutsche Bank Aktiengesellschaft lowered their price objective on agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. Stifel Nicolaus reduced their target price on agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a research report on Tuesday. Barclays decreased their target price on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research report on Monday. Finally, Benchmark reissued a “buy” rating and issued a $9.00 price target on shares of agilon health in a research report on Thursday, August 8th. Three investment analysts have rated the stock with a sell rating, fifteen have issued a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $6.98.

agilon health Stock Performance

AGL traded down $0.02 during midday trading on Wednesday, reaching $1.85. The company’s stock had a trading volume of 1,112,820 shares, compared to its average volume of 4,955,210. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The company has a fifty day simple moving average of $3.18 and a 200 day simple moving average of $4.93. The stock has a market cap of $762.24 million, a P/E ratio of -1.97 and a beta of 0.60. agilon health has a twelve month low of $1.80 and a twelve month high of $13.76.

agilon health (NYSE:AGL) last announced its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The company had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. During the same period last year, the firm posted ($0.06) EPS. Research analysts expect that agilon health will post -0.35 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Steven Sell acquired 20,000 shares of agilon health stock in a transaction on Thursday, September 12th. The shares were purchased at an average price of $3.36 per share, with a total value of $67,200.00. Following the acquisition, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 3.20% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Quantbot Technologies LP bought a new stake in shares of agilon health during the 3rd quarter valued at $1,742,000. Dynamic Technology Lab Private Ltd acquired a new stake in shares of agilon health during the third quarter worth $171,000. Algert Global LLC increased its holdings in agilon health by 80.2% in the third quarter. Algert Global LLC now owns 184,530 shares of the company’s stock valued at $725,000 after purchasing an additional 82,123 shares during the last quarter. Citigroup Inc. lifted its stake in agilon health by 2,251.5% in the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after buying an additional 1,941,993 shares during the period. Finally, Intech Investment Management LLC acquired a new position in shares of agilon health during the 3rd quarter worth about $228,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.